These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24331361)

  • 1. Mitochondrial dysfunction in demyelinating diseases.
    Carvalho KS
    Semin Pediatr Neurol; 2013 Sep; 20(3):194-201. PubMed ID: 24331361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
    Witte ME; Mahad DJ; Lassmann H; van Horssen J
    Trends Mol Med; 2014 Mar; 20(3):179-87. PubMed ID: 24369898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
    Barrette B; Nave KA; Edgar JM
    Biol Chem; 2013 Dec; 394(12):1571-81. PubMed ID: 23959664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis.
    Campbell G; Mahad DJ
    FEBS Lett; 2018 Apr; 592(7):1113-1121. PubMed ID: 29453889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction in epilepsy.
    Khurana DS; Valencia I; Goldenthal MJ; Legido A
    Semin Pediatr Neurol; 2013 Sep; 20(3):176-87. PubMed ID: 24331359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?
    Witte ME; Geurts JJ; de Vries HE; van der Valk P; van Horssen J
    Mitochondrion; 2010 Aug; 10(5):411-8. PubMed ID: 20573557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting mitochondria to protect axons in progressive MS.
    Campbell G; Licht-Mayer S; Mahad D
    Neurosci Lett; 2019 Sep; 710():134258. PubMed ID: 31082453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.
    Valenti D; de Bari L; De Filippis B; Henrion-Caude A; Vacca RA
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():202-17. PubMed ID: 24548784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria and the link between neuroinflammation and neurodegeneration.
    Di Filippo M; Chiasserini D; Tozzi A; Picconi B; Calabresi P
    J Alzheimers Dis; 2010; 20 Suppl 2():S369-79. PubMed ID: 20463396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal and neuronal degeneration in myelin diseases.
    Ohno N; Ikenaka K
    Neurosci Res; 2019 Feb; 139():48-57. PubMed ID: 30179642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction in neuromuscular disorders.
    Katsetos CD; Koutzaki S; Melvin JJ
    Semin Pediatr Neurol; 2013 Sep; 20(3):202-15. PubMed ID: 24331362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron and copper in progressive demyelination--New lessons from Skogholt's disease.
    Aspli KT; Flaten TP; Roos PM; Holmøy T; Skogholt JH; Aaseth J
    J Trace Elem Med Biol; 2015; 31():183-7. PubMed ID: 25563774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial changes associated with demyelination: consequences for axonal integrity.
    Campbell GR; Mahad DJ
    Mitochondrion; 2012 Mar; 12(2):173-9. PubMed ID: 21406249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heterogeneity of the mechanisms of damaging nervous cells in demyelinating autoimmune diseases of the CNS].
    Abdurasulova IN; Klimenko VM
    Ross Fiziol Zh Im I M Sechenova; 2010 Jan; 96(1):50-68. PubMed ID: 20297692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy.
    Ravera S; Nobbio L; Visigalli D; Bartolucci M; Calzia D; Fiorese F; Mancardi G; Schenone A; Morelli A; Panfoli I
    J Neurochem; 2013 Jul; 126(1):82-92. PubMed ID: 23578247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remyelination in demyelinating disease.
    Scolding NJ; Franklin RJ
    Baillieres Clin Neurol; 1997 Oct; 6(3):525-48. PubMed ID: 10101588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axon-oligodendrocyte interactions during developmental myelination, demyelination and repair.
    Piaton G; Gould RM; Lubetzki C
    J Neurochem; 2010 Sep; 114(5):1243-60. PubMed ID: 20524961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.
    Silvestroff L; Bartucci S; Pasquini J; Franco P
    Exp Neurol; 2012 May; 235(1):357-67. PubMed ID: 22421533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.